iBio Inc (NASDAQ: IBIO) kicked off on Monday, up 5.88% from the previous trading day, before settling in for the closing price of $0.74. Over the past 52 weeks, IBIO has traded in a range of $0.64-$6.89.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 57.55% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 56.08%. With a float of $15.30 million, this company’s outstanding shares have now reached $16.22 million.
In an organization with 19 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 298.4%, operating margin of -4483.47%, and the pretax margin is -4389.33%.
iBio Inc (IBIO) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of iBio Inc is 5.67%, while institutional ownership is 15.95%. The most recent insider transaction that took place on Jan 10 ’25, was worth 25,000. In this transaction Chief Financial Officer of this company bought 9,191 shares at a rate of $2.72, taking the stock ownership to the 11,139 shares. Before that another transaction happened on Jan 10 ’25, when Company’s insider bought 9,191 for $2.72, making the entire transaction worth $25,000. This insider now owns 18,316 shares in total.
iBio Inc (IBIO) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.2 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 56.08% per share during the next fiscal year.
iBio Inc (NASDAQ: IBIO) Trading Performance Indicators
Take a look at iBio Inc’s (IBIO) current performance indicators. Last quarter, stock had a quick ratio of 1.12. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 33.50.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.33, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -0.82 in one year’s time.
Technical Analysis of iBio Inc (IBIO)
Let’s dig in a bit further. During the last 5-days, its volume was 0.98 million. That was inferior than the volume of 1.59 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 20.98%.
During the past 100 days, iBio Inc’s (IBIO) raw stochastic average was set at 2.38%, which indicates a significant decrease from 29.06% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 102.64% in the past 14 days, which was lower than the 170.85% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8480, while its 200-day Moving Average is $2.4361. However, in the short run, iBio Inc’s stock first resistance to watch stands at $0.8225. Second resistance stands at $0.8603. The third major resistance level sits at $0.9143. If the price goes on to break the first support level at $0.7307, it is likely to go to the next support level at $0.6767. The third support level lies at $0.6389 if the price breaches the second support level.
iBio Inc (NASDAQ: IBIO) Key Stats
The company with the Market Capitalisation of 12.73 million has total of 16,519K Shares Outstanding. Its annual sales at the moment are 230 K in contrast with the sum of -24,910 K annual income. Company’s last quarter sales were recorded 200 K and last quarter income was -4,360 K.
